Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

F Fantini; A Greco; C Del Giovane; Am Cesinaro; M Venturini; C Zane; T Surrenti; Ketty Peris; Pg Calzavara Pinton

doi:10.1111/j.1468-3083.2010.03877.x

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

F Fantini, A Greco, C Del Giovane, Am Cesinaro, M Venturini, C Zane, T Surrenti, Ketty Peris, Pg Calzavara Pinton

Risultato della ricerca: Contributo in rivista › Articolo

66 Citazioni (Scopus)

Abstract

Photodynamic therapy (PDT) is increasingly used in the treatment of basal cell carcinoma (BCC). However, scant information is available about the impact of both patient- and lesion-related characteristics on the effectiveness of therapy. Therefore, on the basis of the current data, it is difficult to draw clear-cut indications to use PDT for treatment of BCC in clinical practice.

Lingua originale	Inglese
pagine (da-a)	896-901
Numero di pagine	6
Rivista	Journal of the European Academy of Dermatology and Venereology
Volume	25
Numero di pubblicazione	8
DOI	https://doi.org/10.1111/j.1468-3083.2010.03877.x
Stato di pubblicazione	Pubblicato - 2011

Keywords

80 and over
Age Factors
Aged
Aminolevulinic Acid
Basal Cell
Carcinoma
Extremities
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Photochemotherapy
Photosensitizing Agents
Retrospective Studies
Sex Factors
Skin Neoplasms
Torso
Treatment Outcome

Accesso al documento

10.1111/j.1468-3083.2010.03877.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{65633c1de05f4beb88c9827340b008ee,

title = "Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response",

abstract = "Photodynamic therapy (PDT) is increasingly used in the treatment of basal cell carcinoma (BCC). However, scant information is available about the impact of both patient- and lesion-related characteristics on the effectiveness of therapy. Therefore, on the basis of the current data, it is difficult to draw clear-cut indications to use PDT for treatment of BCC in clinical practice.",

keywords = "80 and over, Age Factors, Aged, Aminolevulinic Acid, Basal Cell, Carcinoma, Extremities, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Photochemotherapy, Photosensitizing Agents, Retrospective Studies, Sex Factors, Skin Neoplasms, Torso, Treatment Outcome, 80 and over, Age Factors, Aged, Aminolevulinic Acid, Basal Cell, Carcinoma, Extremities, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Photochemotherapy, Photosensitizing Agents, Retrospective Studies, Sex Factors, Skin Neoplasms, Torso, Treatment Outcome",

author = "F Fantini and A Greco and {Del Giovane}, C and Am Cesinaro and M Venturini and C Zane and T Surrenti and Ketty Peris and {Calzavara Pinton}, Pg",

year = "2011",

doi = "10.1111/j.1468-3083.2010.03877.x",

language = "English",

volume = "25",

pages = "896--901",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

AU - Fantini, F

AU - Greco, A

AU - Del Giovane, C

AU - Cesinaro, Am

AU - Venturini, M

AU - Zane, C

AU - Surrenti, T

AU - Peris, Ketty

AU - Calzavara Pinton, Pg

PY - 2011

Y1 - 2011

N2 - Photodynamic therapy (PDT) is increasingly used in the treatment of basal cell carcinoma (BCC). However, scant information is available about the impact of both patient- and lesion-related characteristics on the effectiveness of therapy. Therefore, on the basis of the current data, it is difficult to draw clear-cut indications to use PDT for treatment of BCC in clinical practice.

AB - Photodynamic therapy (PDT) is increasingly used in the treatment of basal cell carcinoma (BCC). However, scant information is available about the impact of both patient- and lesion-related characteristics on the effectiveness of therapy. Therefore, on the basis of the current data, it is difficult to draw clear-cut indications to use PDT for treatment of BCC in clinical practice.

KW - 80 and over

KW - Age Factors

KW - Aged

KW - Aminolevulinic Acid

KW - Basal Cell

KW - Carcinoma

KW - Extremities

KW - Female

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Photochemotherapy

KW - Photosensitizing Agents

KW - Retrospective Studies

KW - Sex Factors

KW - Skin Neoplasms

KW - Torso

KW - Treatment Outcome

KW - 80 and over

KW - Age Factors

KW - Aged

KW - Aminolevulinic Acid

KW - Basal Cell

KW - Carcinoma

KW - Extremities

KW - Female

KW - Head and Neck Neoplasms

KW - Humans

KW - Male

KW - Middle Aged

KW - Photochemotherapy

KW - Photosensitizing Agents

KW - Retrospective Studies

KW - Sex Factors

KW - Skin Neoplasms

KW - Torso

KW - Treatment Outcome

UR - https://publicatt.unicatt.it/handle/10807/56425

U2 - 10.1111/j.1468-3083.2010.03877.x

DO - 10.1111/j.1468-3083.2010.03877.x

M3 - Article

SN - 0926-9959

VL - 25

SP - 896

EP - 901

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 8

ER -

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo